MRSA Research Today is a free monthly online journal that collates and summarizes the latest research about MRSA, including details on methicillin-resistant staphylococcus aureus, hospitals, infection, antibiotic resistance, superbugs.

Volume 6 (2009), Issue 10 (October)

1. Wound chronicity, inpatient care, and chronic kidney disease predispose to MRSA infection in diabetic foot ulcers.
   Diabetes Care, 32(10): 1907-9. [Abstract] [Full-text]
2. Impact of a short period of pre-enrichment on detection and bacterial loads of methicillin-resistant Staphylococcus aureus from screening specimens.
   J Clin Microbiol, 47(10): 3326-8. [Abstract] [Full-text]
3. Molecular surveillance and population structure analysis of methicillin-susceptible and methicillin-resistant Staphylococcus aureus in high-risk wards.
   J Clin Microbiol, 47(10): 3246-54. [Abstract] [Full-text]
4. Community-associated methicillin-resistant Staphylococcus aureus mediastinitis.
   J Clin Microbiol, 47(10): 3367-9. [Abstract] [Full-text]
5. Microscopic polyangiitis triggered by recurrent methicillin-resistant Staphylococcus aureus bacteremia.
   Int Urol Nephrol. [Abstract] [Full-text]
6. Improved multiple-locus variable-number tandem-repeat assay for Staphylococcus aureus genotyping, providing a highly informative technique together with strong phylogenetic value.
   J Clin Microbiol, 47(10): 3121-8. [Abstract] [Full-text]
7. Comparison of fingerprinting methods for typing methicillin-resistant Staphylococcus aureus sequence type 398.
   J Clin Microbiol, 47(10): 3313-22. [Abstract] [Full-text]
8. Daptomycin in bone and joint infections: a review of the literature.
   Arch Orthop Trauma Surg, 129(11): 1495-504. [Abstract] [Full-text]
9. Molecular epidemiology of Staphylococcus aureus in asymptomatic carriers.
   Eur J Clin Microbiol Infect Dis, 28(9): 1159-65. [Abstract] [Full-text]
10. Prevalence of Staphylococcus aureus strains in an Australian cohort, 1989-2003: evidence for the low prevalence of the toxic shock toxin and Panton-Valentine leukocidin genes.
    Eur J Clin Microbiol Infect Dis, 28(10): 1183-9. [Abstract] [Full-text]
11. Clinical and molecular epidemiology of ciprofloxacin-susceptible MRSA encoding PVL in England and Wales.
    Eur J Clin Microbiol Infect Dis, 28(9): 1113-21. [Abstract] [Full-text]
12. Evaluation of a commercial MRSA assay when multiple MRSA strains are causing epidemics.
    Eur J Clin Microbiol Infect Dis, 28(10): 1271-3. [Abstract] [Full-text]
13. Costs and benefits of the MRSA Search and Destroy policy in a Dutch hospital.
    Eur J Clin Microbiol Infect Dis, 28(10): 1245-52. [Abstract] [Full-text]
14. Prophylactic antibiotics in hip and knee arthroplasty.
    J Bone Joint Surg Am, 91(10): 2480-90. [Abstract] [Full-text]
15. Pus and free bone flaps.
    J Neurosurg Pediatr, 4(4): 378-82. [Abstract] [Full-text]
16. Staphylococcus aureus colonization of anterior nares of school going children.
    Indian J Pediatr, 76(8): 813-6. [Abstract] [Full-text]
17. Bacteriologic features of surgical site infections following breast surgery.
    Am J Surg, 198(4): 529-31. [Abstract] [Full-text]
18. The significant but understudied impact of pathogen transmission from humans to animals.
    Mt Sinai J Med, 76(5): 448-55. [Abstract] [Full-text]
19. An update on community-associated MRSA virulence.
    Curr Opin Pharmacol, 9(5): 545-51. [Abstract] [Full-text]
20. Clinical spectrum of gram-positive infections in lung transplantation.
    Transpl Infect Dis, 11(5): 424-31. [Abstract] [Full-text]
21. Topical antibiotic treatment for uncomplicated skin and skin structure infections: review of the literature.
    Expert Rev Anti Infect Ther, 7(8): 957-65. [Abstract] [Full-text]
22. A comparison of linezolid with glycopeptides in severe MRSA pneumonia.
    Expert Rev Anti Infect Ther, 7(8): 951-5. [Abstract] [Full-text]
23. Current challenges in viral hepatitis, antimicrobial resistance and the influenza pandemic.
    Expert Rev Anti Infect Ther, 7(8): 945-9. [Abstract] [Full-text]
24. Discovery and structure-activity relationship analysis of Staphylococcus aureus sortase A inhibitors.
    Bioorg Med Chem, 17(20): 7174-85. [Abstract] [Full-text]
25. The mode of antistaphylococcal action of Eleutherine americana.
    FEMS Immunol Med Microbiol, 57(2): 193-201. [Abstract] [Full-text]
26. Antibacterial activity of aminoderivatized chitosans against methicillin-resistant Staphylococcus aureus (MRSA).
    Bioorg Med Chem, 17(20): 7108-12. [Abstract] [Full-text]
27. Molecular identification and genotyping of MRSA isolates.
    FEMS Immunol Med Microbiol, 57(2): 104-15. [Abstract] [Full-text]
28. Antibiotic resistance in community-acquired pneumonia caused by Streptococcus pneumoniae, methicillin-resistant Staphylococcus aureus, and Acinetobacter baumannii.
    Chest, 136(4): 1119-27. [Abstract] [Full-text]
29. A novel approach for salvaging infected prosthetic mesh after ventral hernia repair.
    Hernia, 13(5): 545-9. [Abstract] [Full-text]
30. A retrospective analysis of changes in inflammatory markers in patients treated with bacterial viruses.
    Clin Exp Med, 9(4): 303-12. [Abstract] [Full-text]
31. Emerging Infections in Burns.
    Surg Infect (Larchmt). [Abstract] [Full-text]
32. Empirical antimicrobial therapy for bloodstream infection due to methicillin-resistant Staphylococcus aureus: no better than a coin toss.
    Infect Control Hosp Epidemiol, 30(11): 1057-61. [Abstract] [Full-text]
33. Usefulness of weekly methicillin-resistant Staphylococcus aureus screening.
    Infect Control Hosp Epidemiol, 30(11): 1113-5. [Abstract] [Full-text]
34. Mortality of S. aureus bacteremia and infectious diseases specialist consultation - a study of 521 patients in Germany.
    J Infect, 59(4): 232-9. [Abstract] [Full-text]
35. Vancomycin dosing for pneumonia in critically ill trauma patients.
    J Trauma, 67(4): 802-4. [Abstract] [Full-text]
36. Bacterial contamination on touch surfaces in the public transport system and in public areas of a hospital in London.
    Lett Appl Microbiol. [Abstract] [Full-text]
37. Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.
    J Infect Dis, 200(9): 1355-66. [Abstract] [Full-text]
38. Functional and biochemical analysis of a key series of ramoplanin analogues.
    Bioorg Med Chem Lett, 19(21): 6189-91. [Abstract] [Full-text]
39. Potential therapeutic failure of generic vancomycin in a liver transplant patient with MRSA peritonitis and bacteremia.
    J Infect, 59(4): 277-80. [Abstract] [Full-text]
40. Enhanced surveillance of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in children in the UK and Ireland.
    Arch Dis Child. [Abstract] [Full-text]
41. Comparative antibacterial effects of daptomycin, vancomycin and teicoplanin studied in an in vitro pharmacokinetic model of infection.
    J Antimicrob Chemother, 64(5): 1044-51. [Abstract] [Full-text]
42. Emergence of multiresistant variants of the community-acquired methicillin-resistant Staphylococcus aureus lineage ST1-SCCmecIV in 2 hospitals in Rio de Janeiro, Brazil.
    Diagn Microbiol Infect Dis, 65(3): 300-5. [Abstract] [Full-text]
43. Has the publication of methicillin-resistant Staphylococcus aureus (MRSA) treatment guidelines increased the survival associated with MRSA bacteraemia?
    J Antimicrob Chemother, 64(5): 1111-3. [Abstract] [Full-text]
44. Occurrence of vancomycin-tolerant and heterogeneous vancomycin-intermediate strains (hVISA) among Staphylococcus aureus causing bloodstream infections in nine USA hospitals.
    J Antimicrob Chemother, 64(5): 1024-8. [Abstract] [Full-text]
45. Swine flu and antibiotics.
    J Antimicrob Chemother, 64(5): 889-94. [Abstract] [Full-text]
46. In vitro activity of tigecycline and comparator agents against a global collection of Gram-negative and Gram-positive organisms: tigecycline Evaluation and Surveillance Trial 2004 to 2007.
    Diagn Microbiol Infect Dis, 65(3): 288-99. [Abstract] [Full-text]
47. The clinical consequences of antimicrobial resistance.
    Curr Opin Microbiol, 12(5): 476-81. [Abstract] [Full-text]
48. Staphylococcus aureus alpha-hemolysin activates the NLRP3-inflammasome in human and mouse monocytic cells.
    PLoS One, 4(10): e7446. [Abstract] [Full-text]
49. Total synthesis and biological evaluation of (+)- and (-)-bisanthraquinone antibiotic BE-43472B and related compounds.
    J Am Chem Soc, 131(41): 14812-26. [Abstract] [Full-text]
50. In vitro characterization of enzymes involved in the synthesis of nonproteinogenic residue (2S,3S)-beta-methylphenylalanine in glycopeptide antibiotic mannopeptimycin.
    Chembiochem, 10(15): 2480-7. [Abstract] [Full-text]
51. Community-acquired methicillin-resistant Staphylococcus aureus and Lemierre syndrome.
    Am J Med Sci, 338(4): 326-7. [Abstract] [Full-text]
52. Scapular Abscess, Septic Emboli, and Deep Vein Thrombosis in a Healthy Child Due to Community-Acquired Methicillin-Resistant Staphylococcus aureus: Case Report.
    Pediatr Emerg Care, 25(10): 677-80. [Abstract] [Full-text]
53. Using a longitudinal model to estimate the effect of methicillin-resistant Staphylococcus aureus infection on length of stay in an intensive care unit.
    Am J Epidemiol, 170(9): 1186-94. [Abstract] [Full-text]
54. Discovery of a small molecule that blocks wall teichoic acid biosynthesis in Staphylococcus aureus.
    ACS Chem Biol, 4(10): 875-83. [Abstract] [Full-text]
55. VanA-type vancomycin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother, 53(11): 4580-7. [Abstract] [Full-text]
56. In vitro antibacterial activity of porous TiO2-Ag composite layers against methicillin-resistant Staphylococcus aureus.
    Acta Biomater, 5(9): 3573-80. [Abstract] [Full-text]
57. Regional trends in multidrug-resistant infections in German intensive care units: a real-time model for epidemiological monitoring and analysis.
    J Hosp Infect, 73(3): 239-45. [Abstract] [Full-text]
58. Inactivation of staphylococcal virulence factors using a light-activated antimicrobial agent.
    BMC Microbiol, 9: 211. [Abstract] [Full-text]
59. Suffering from meticillin-resistant Staphylococcus aureus: experiences and understandings of colonisation.
    J Hosp Infect, 73(3): 271-7. [Abstract] [Full-text]
60. UK healthcare workers' knowledge of meticillin-resistant Staphylococcus aureus practice guidelines; a questionnaire study.
    J Hosp Infect, 73(3): 264-70. [Abstract] [Full-text]
61. Clinical and molecular characteristics of nosocomial meticillin-resistant Staphylococcus aureus skin and soft tissue isolates from three Indian hospitals.
    J Hosp Infect, 73(3): 253-63. [Abstract] [Full-text]
62. Oral microbial and respiratory status of persons with mental retardation/intellectual and developmental disability: an observational cohort study.
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod, 108(5): 722-31. [Abstract] [Full-text]
63. In vitro activities of three new dihydrofolate reductase inhibitors against clinical isolates of gram-positive bacteria.
    Antimicrob Agents Chemother, 53(11): 4949-52. [Abstract] [Full-text]
64. In vitro activity of nemonoxacin, a novel nonfluorinated quinolone, against 2,440 clinical isolates.
    Antimicrob Agents Chemother, 53(11): 4915-20. [Abstract] [Full-text]
65. In vitro activity of ceftaroline against methicillin-resistant Staphylococcus aureus and heterogeneous vancomycin-intermediate S. aureus in a hollow fiber model.
    Antimicrob Agents Chemother, 53(11): 4712-7. [Abstract] [Full-text]
66. Panton-Valentine leukocidin-positive methicillin-resistant Staphylococcus aureus infections in children with cancer.
    Pediatr Blood Cancer, 53(7): 1216-20. [Abstract] [Full-text]
67. Unexpected sequence types in livestock associated methicillin-resistant Staphylococcus aureus (MRSA): MRSA ST9 and a single locus variant of ST9 in pig farming in China.
    Vet Microbiol, 139(3): 405-9. [Abstract] [Full-text]
68. Identification of a predominant multilocus sequence type, pulsed-field gel electrophoresis cluster, and novel staphylococcal chromosomal cassette in clinical isolates of mecA-containing, methicillin-resistant Staphylococcus pseudintermedius.
    Vet Microbiol, 139(3): 333-8. [Abstract] [Full-text]
69. Antibacterial activity of 2-(2',4'-dibromophenoxy)-4,6-dibromophenol from Dysidea granulosa.
    Mar Drugs, 7(3): 464-71. [Abstract] [Full-text]
70. Microbiology, time course and clinical characteristics of infection in critically ill patients receiving packed red blood cell transfusion.
    Vox Sang, 97(4): 294-302. [Abstract] [Full-text]
71. Epidemiology and susceptibilities of methicillin-resistant Staphylococcus aureus in Northeastern Ohio.
    Am J Clin Pathol, 132(5): 668-77. [Abstract] [Full-text]
72. Epidemiology and Clinical Features of Community-Acquired, Healthcare Associated and Nosocomial Bloodstream Infections in Tertiary and Community Hospitals.
    Clin Microbiol Infect. [Abstract] [Full-text]
73. Health-care associated infections rates, length of stay, and bacterial resistance in an intensive care unit of Morocco: Findings of the International Nosocomial Infection Control Consortium (INICC).
    Int Arch Med, 2(1): 29. [Abstract] [Full-text]
74. Methicillin-resistant Staphylococcus aureus and Acinetobacter baumannii on computer interface surfaces of hospital wards and association with clinical isolates.
    BMC Infect Dis, 9: 164. [Abstract] [Full-text]
75. Genetic diversity in CC398 methicillin-resistant Staphylococcus aureus isolates of different geographical origin.
    Clin Microbiol Infect. [Abstract] [Full-text]
76. Norselic acids A-E, highly oxidized anti-infective steroids that deter mesograzer predation, from the Antarctic sponge Crella sp.
    J Nat Prod, 72(10): 1842-6. [Abstract] [Full-text]
77. Colonization of residents and staff of a long-term-care facility and adjacent acute-care hospital geriatric unit by multiresistant bacteria.
    Clin Microbiol Infect. [Abstract] [Full-text]
78. How common is MRSA in adult septic arthritis?
    Ann Emerg Med, 54(5): 695-700. [Abstract] [Full-text]
79. The inhibitory effect of vancomycin ointment on the manifestation of MRSA keratitis in rabbits.
    J Infect Chemother, 15(5): 279-83. [Abstract] [Full-text]
80. Characterization of beta-lactam antibiotic-induced vancomycin-resistant MRSA (BIVR) in a patient with septicemia during long-term vancomycin administration.
    J Infect Chemother, 15(5): 274-8. [Abstract] [Full-text]
81. Methicillin-resistant Staphylococcus aureus infection after lung transplantation: 5-year review of clinical and molecular epidemiology.
    J Heart Lung Transplant, 28(11): 1231-6. [Abstract] [Full-text]
82. Fatal co-infection with swine origin influenza virus A/H1N1 and community-acquired methicillin-resistant Staphylococcus aureus.
    J Infect, 59(5): 366-70. [Abstract] [Full-text]
83. Current bacteriology of chronic otitis media with effusion: high rate of nosocomial infection and decreased antibiotic sensitivity.
    J Infect, 59(5): 308-16. [Abstract] [Full-text]
84. Airborne transmission of disease in hospitals.
    J R Soc Interface, 6: S697-702. [Abstract] [Full-text]
85. Basic approach for the selection of antibacterial agents.
    Respirology, 14: S23-37. [Abstract] [Full-text]
86. Diagnosis of hospital-acquired pneumonia and methods of testing for pathogens.
    Respirology, 14: S10-22. [Abstract] [Full-text]
87. Staphylococcus aureus synthesizes adenosine to escape host immune responses.
    J Exp Med, 206(11): 2417-27. [Abstract] [Full-text]
88. Diverse enterotoxin gene profiles among clonal complexes of Staphylococcus aureus isolates from the Bronx, New York.
    Appl Environ Microbiol, 75(21): 6839-49. [Abstract] [Full-text]
89. Treating Gram-positive infections: vancomycin update and the whys, wherefores and evidence base for continuous infusion of anti-Gram-positive antibiotics.
    Curr Opin Infect Dis, 22(6): 525-34. [Abstract] [Full-text]
90. TLN-05220, TLN-05223, new Echinosporamicin-type antibiotics, and proposed revision of the structure of bravomicins(*).
    J Antibiot (Tokyo), 62(10): 565-70. [Abstract] [Full-text]
91. Synthesis and combinational antibacterial study of 5''-modified neomycin.
    J Antibiot (Tokyo), 62(10): 539-44. [Abstract] [Full-text]
92. Total syntheses of (+/-)-platencin and (-)-platencin.
    J Am Chem Soc, 131(43): 15909-17. [Abstract] [Full-text]
93. Analyzing the catalytic mechanism of protein tyrosine phosphatase PtpB from Staphylococcus aureus through site-directed mutagenesis.
    Int J Biol Macromol, 45(5): 463-9. [Abstract] [Full-text]
94. Reducing MRSA infections in college student athletes: implementation of a prevention program.
    J Community Health Nurs, 26(4): 161-72. [Abstract] [Full-text]
95. Accuracy of American Thoracic Society/Infectious Diseases Society of America criteria in predicting infection or colonization with multidrug-resistant bacteria at intensive-care unit admission.
    Clin Microbiol Infect. [Abstract] [Full-text]
96. Surveillance for severe community-associated methicillin-resistant Staphylococcus aureus infection.
    Epidemiol Infect, 137(12): 1674-8. [Abstract] [Full-text]
97. Use of atmospheric non-thermal plasma as a disinfectant for objects contaminated with methicillin-resistant Staphylococcus aureus.
    Am J Infect Control, 37(9): 729-33. [Abstract] [Full-text]

© 2004-2012 MRSA Research Today. All Rights Reserved.